J&J CEO sends a clear message on the obesity drug boom
Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of…
J&J lays out plan to splinter orthopedics business into separate company
Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.…